{"id":"CHEMBL1059","canonicalSmiles":"CC(C)C[C@H](CN)CC(=O)O","inchiKey":"AYXYPKUFHZROOJ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGABALIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alzain","Axalid","Lecaent","Lyrica","Lyrica cr","Pregabalin","Rewisca"],"synonyms":["CI-1008","PD-144723","Pregabalin","YNP-1807"],"crossReferences":{"DailyMed":["pregabalin"],"PubChem":["144205028"],"Wikipedia":["Pregabalin"],"drugbank":["DB00230"],"chEBI":["64356"]},"count":44,"approvedIndications":["EFO_0005762","EFO_0005687","EFO_0009430","EFO_0000474","HP_0001250"],"linkedTargets":{"rows":["ENSG00000153956"],"count":1},"linkedDiseases":{"rows":["HP_0000989","HP_0012735","EFO_0000555","MONDO_0002959","EFO_0003768","EFO_0004698","EFO_0003829","MONDO_0004892","HP_0002018","EFO_0003931","EFO_0002506","EFO_0004263","EFO_0000182","EFO_0004616","HP_0003419","EFO_0006510","EFO_1000789","HP_0008419","EFO_0000400","EFO_0000692","EFO_0005762","EFO_1001931","EFO_1000877","HP_0012532","EFO_1000906","EFO_0003821","EFO_0000731","EFO_0003830","EFO_0000342","EFO_0003108","EFO_1001998","EFO_0005687","HP_0000726","MONDO_0007254","EFO_0009846","EFO_0002950","EFO_0007191","EFO_0009562","EFO_1000783","EFO_0000474","MONDO_0002050","EFO_0009430","EFO_0003100","EFO_0004257","EFO_0004242","EFO_0000707","EFO_0005230","EFO_0007490","HP_0002069","EFO_0009558","EFO_1001884","HP_0001250","EFO_0003843","HP_0002315","EFO_1001892","EFO_0003890","EFO_1000781","EFO_0003766","EFO_0005611","EFO_0004149","EFO_0004270"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 5 approved and 39 investigational indications."}
{"id":"CHEMBL107360","canonicalSmiles":"c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2","inchiKey":"JCBQCKFFSPGEDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINUPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinupramine"],"crossReferences":{"drugbank":["DB13246"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1084081","canonicalSmiles":"O=C(O)c1ccc(B(O)O)cc1NS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)cs1","inchiKey":"JJPKFZAOXOEFHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084081","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1095","canonicalSmiles":"CCN1C(=O)NC(c2ccccc2)C1=O","inchiKey":"SZQIFWWUIBRPBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOTOIN","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Peganone"],"synonyms":["Ethotoin"],"crossReferences":{"DailyMed":["ethotoin"],"PubChem":["144203934","56463534"],"Wikipedia":["Ethotoin"],"drugbank":["DB00754"],"chEBI":["4888"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for epilepsy."}
{"id":"CHEMBL1096882","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"GIUYCYHIANZCFB-FJFJXFQQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUDARABINE PHOSPHATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["Fludarabine","Fludarabine 5'-monophosphate","Fludarabine phosphate","NSC-312887","NSC-328002"],"crossReferences":{"DailyMed":["fludarabine%20phosphate"],"chEBI":["63599"]},"count":121,"approvedIndications":["EFO_0000616","EFO_0000095","EFO_0002422","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000167325","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_1001257","EFO_1000403","EFO_0000637","EFO_0000756","EFO_0000681","EFO_0005952","EFO_0006803","EFO_1000318","MONDO_0015760","EFO_1001935","EFO_0000339","EFO_0000096","EFO_0002690","MONDO_0020511","EFO_1000956","Orphanet_3319","MONDO_0008903","EFO_0000588","EFO_0000676","Orphanet_42738","Orphanet_379","MONDO_0000159","EFO_0000198","MONDO_0013730","EFO_0005803","EFO_0000221","MONDO_0019465","EFO_0001642","EFO_1000309","EFO_0000384","MONDO_0008315","EFO_1000026","MONDO_0002691","HP_0002721","MONDO_0009453","MONDO_0044889","EFO_0003032","MONDO_0019472","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000550","EFO_1000142","Orphanet_231214","Orphanet_84","MONDO_0044903","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0003541","EFO_0002430","MONDO_0002158","EFO_1001996","EFO_0004289","EFO_0000196","EFO_0000183","MONDO_0002083","Orphanet_447","EFO_1000388","EFO_0000616","EFO_0006859","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0007576","MONDO_0019469","EFO_0004599","EFO_0003885","EFO_0002517","EFO_0006927","MONDO_0002367","Orphanet_2781","MONDO_0018906","HP_0100727","MONDO_0024880","EFO_0000519","MONDO_0000873","EFO_0003869","EFO_0001075","Orphanet_183660","EFO_1000131","Orphanet_848","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0009709","MONDO_0019088","EFO_0000389","MONDO_0019460","EFO_0000330","EFO_0000182","EFO_1000785","EFO_0000094","EFO_0003802","EFO_0009441","EFO_0005761","EFO_1000292","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000223","MONDO_0044881","EFO_0002429","EFO_0003025","EFO_0009708","MONDO_0019474","Orphanet_811","EFO_0006926","MONDO_0001023","MONDO_0021193","EFO_0002428","EFO_1001051","EFO_0000218","EFO_1000102","MONDO_0002542","MONDO_0019471","EFO_0003812","Orphanet_232","MONDO_0015686","EFO_1001945","EFO_0003778","EFO_1001469","HP_0001915","MONDO_0002087","EFO_0000209","EFO_0000708","EFO_1002048","EFO_1000690","EFO_1000218","Orphanet_906","MONDO_0001657","EFO_0004272","MONDO_0020743","EFO_0000717","EFO_0002617","EFO_0000685","EFO_1000616","EFO_0002422","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0003865","EFO_0000095","EFO_0000174","EFO_0006475","EFO_0000191","EFO_1000560","MONDO_0020077","EFO_0000691","EFO_0003811","EFO_0003027"],"count":155},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 117 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL109962","canonicalSmiles":"N[C@@H](C[SeH])C(=O)O","inchiKey":"ZKZBPNGNEQAJSX-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENOCYSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Selenocysteine"],"drugbank":["DB02345"],"chEBI":["16633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1109","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1","inchiKey":"QWCJHSGMANYXCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPHENAZOLE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orisulf","Sulfabid"],"synonyms":["Sulfafenazol","Sulfaphenazole","Sulphaphenazole"],"crossReferences":{"PubChem":["11111774","11111775","144203813","170465185","26732624","26747662","46500353","50106998"],"Wikipedia":["Sulfaphenazole"],"drugbank":["DB06729"],"chEBI":["77780"]},"count":2,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for eye infection and bacterial disease."}
{"id":"CHEMBL1114","canonicalSmiles":"Cn1cnc2c1c(=O)[nH]c(=O)n2C","inchiKey":"YAPQBXQYLJRXSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOBROMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3591","NSC-5039","SC-15090","Theobromine","Theobromine(20%)"],"crossReferences":{"PubChem":["11111888","144203835","170465487","26751592","50104235","85231258","856014","90341332"],"Wikipedia":["Theobromine"],"drugbank":["DB01412"],"chEBI":["28946"]},"childChemblIds":["CHEMBL2106653","CHEMBL2107522","CHEMBL2107523"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1160619","canonicalSmiles":"Cc1cn([C@H]2C[C@H](F)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"GGCAVPJXJISBOA-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160619","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1164","canonicalSmiles":"COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.[Na+]","inchiKey":"MGFZNWDWOKASQZ-UMLIZJHQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHICILLIN SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL575","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Staphcillin"],"synonyms":["SQ-16123"],"crossReferences":{"PubChem":["89856155"],"chEBI":["52065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1199734","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)Oc3ccccc3)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"ZHUWBKDWWGKIEN-FMKGYKFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1199734","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02790"]},"childChemblIds":["CHEMBL1162559"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200354","canonicalSmiles":"CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+]","inchiKey":"FVEFRICMTUKAML-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM TETRADECYL SULFATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201345","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fibro-vein","Fibrovein","S.t.d.","Sotradecol"],"synonyms":["Sodium tetradecyl sulfate","Sodium tetradecyl sulphate"],"crossReferences":{"DailyMed":["sodium%20tetradecyl%20sulfate"],"PubChem":["144205953","144207090","144211872"],"Wikipedia":["Sodium_tetradecyl_sulfate"],"drugbank":["DB00464"],"chEBI":["75273"]},"count":2,"approvedIndications":["HP_0002619"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for varicose veins and has 1 investigational indication."}
{"id":"CHEMBL1200365","canonicalSmiles":"Nc1ccc(C(=O)NCC(=O)[O-])cc1.[Na+]","inchiKey":"UNZMYCAEMNVPHX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOHIPPURATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL463","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aminohippurate sodium"],"synonyms":[".rho.-aminohippuric acid sodium salt","Aminohippurate sodium","P-aminohippurate sodium","Para-aminohippurate sodium [injection]","Sodium p-aminohippurate"],"crossReferences":{"chEBI":["31204"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200464","canonicalSmiles":"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N.Cl","inchiKey":"BFUUJUGQJUTPAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPARACAINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1196","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcaine","Kainair","Ophthaine","Ophthetic","Paracaine","Proparacaine hydrochloride"],"synonyms":["Proparacaine hydrochloride","Proxymetacaine","Proxymetacaine hydrochloride"],"crossReferences":{"DailyMed":["proparacaine%20hydrochloride"],"PubChem":["144207096","170465400","56320661"]},"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["HP_0009926"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1200556","canonicalSmiles":"CC(=O)O.N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"MLSVJHOYXJGGTR-IFHOVBQLSA-N","drugType":"Protein","blackBoxWarning":true,"name":"DESMOPRESSIN ACETATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1429","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Concentraid","Ddavp","Ddavp (needs no refrigeration)","Desmomelt","Desmopressin acetate","Desmopressin acetate (needs no refrigeration)","Desmopressin acetate preservative free","Desmospray","Desmotabs","Minirin","Nocdurna","Noctiva","Nocutil","Noqdirna","Octim","Octostim","Presinex","Stimate","Stimate (needs no refrigeration)"],"synonyms":["Desmopressin acetate","Desmopressin acetate hydrate"],"crossReferences":{"DailyMed":["desmopressin%20acetate"]},"count":4,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148","ENSG00000198049"],"count":3},"linkedDiseases":{"rows":["MP_0001914","MONDO_0024290","EFO_0002508","EFO_0005323","EFO_0005669","Orphanet_98878","EFO_1002048"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for hemorrhage and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200645","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O","inchiKey":"LIQODXNTTZAGID-OCBXBXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOPOSIDE PHOSPHATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Etopophos","Etopophos preservative free"],"synonyms":["BMY 40481","BMY-40481","Etoposide phosphate","VP-16","VP16"],"count":20,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000873","EFO_0004708","EFO_0000220","MONDO_0008170","EFO_0000403","EFO_0000222","EFO_0002939","EFO_1001946","EFO_0002501","EFO_0005952","MONDO_0002087","MONDO_0003541","EFO_0000313","EFO_0002500","EFO_0000621","EFO_0000565","MONDO_0015917","MONDO_0002158","MONDO_0008903","EFO_0000574","EFO_0002918","EFO_1001947","EFO_0001378","EFO_0000183","EFO_1000158"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for neoplasm and has 19 investigational indications."}
{"id":"CHEMBL1200694","canonicalSmiles":"FCOC(C(F)(F)F)C(F)(F)F","inchiKey":"DFEYYRMXOJXZRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVOFLURANE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","Sevoflurane"],"crossReferences":{"DailyMed":["sevoflurane"],"PubChem":["144205978","50112674"],"Wikipedia":["Sevoflurane"],"drugbank":["DB01236"],"chEBI":["9130"]},"count":25,"linkedTargets":{"rows":["ENSG00000169427","ENSG00000109158","ENSG00000145863","ENSG00000082482","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000186795","ENSG00000171303","ENSG00000100433","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000145888","ENSG00000186297","ENSG00000163288"],"count":22},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","EFO_0007486","HP_0012735","EFO_1001328","EFO_0004278","EFO_1001951","HP_0025425","EFO_0003931","EFO_0002506","EFO_0003870","EFO_0000544","EFO_0003884","EFO_1001250","EFO_0001074","EFO_0002687","HP_0001919","EFO_0005323","MP_0001914","MP_0001845","MONDO_0100096","EFO_0004888","EFO_0005109","EFO_0009659","EFO_0004337","EFO_0005251","MONDO_0018373","HP_0000303","EFO_0006834","EFO_1001905","MONDO_0021117","MONDO_0007254","EFO_0009267","EFO_1000637","EFO_1002048","MONDO_0002050","MONDO_0021698","EFO_0003839","EFO_0000694","EFO_0001645","EFO_0005207","HP_0011110","MONDO_0007576","EFO_1001884","MONDO_0004379","HP_0003418","EFO_0001073","EFO_0003843","EFO_0009549","EFO_0002615","EFO_0000537","HP_0000713","EFO_0000311","EFO_0001072","EFO_0000713","EFO_0003890","EFO_0008583","MONDO_0002367","EFO_0000612","EFO_0005611","MONDO_0043510"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 25 investigational indications."}
{"id":"CHEMBL1200705","canonicalSmiles":"Br.CC(N)Cc1ccc(O)cc1","inchiKey":"RZCJLMTXBMNRAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYAMPHETAMINE HYDROBROMIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1546","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paredrine"],"synonyms":["Hydroxyamphetamine hydrobromide","Hyroxyamfetamine hydrobromide","Oxamphetamine hydrobromide"],"crossReferences":{"DailyMed":["hydroxyamphetamine%20hydrobromide"],"PubChem":["124752968","124752971","144205040","26749172"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL1200841","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1.Cl","inchiKey":"HCBIBCJNVBAKAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCAINE HYDROCHLORIDE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL569","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novocain","Pasconeural n","Procaine hydrochloride"],"synonyms":["Procaine hydrochloride","SP-01A","SP01A","Sp01a"],"crossReferences":{"PubChem":["144203799","144212431","170464937","50085977","50106847"],"chEBI":["8431"]},"count":1,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and has 1 investigational indication."}
{"id":"CHEMBL1200920","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.Cl","inchiKey":"MUFDLGGSOCHQOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOETHARINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201213","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-2","Bronkosol","Isoetharine hydrochloride","Isoetharine hydrochloride s/f","Numotac"],"synonyms":["Isoetarine hydrochloride","Isoetharine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201039","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O","inchiKey":"NDTSRXAMMQDVSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZTHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquatag","Benzthiazide","Exna","Fovane","Urese"],"synonyms":["Benzthiazide"],"crossReferences":{"PubChem":["11112238","124882104","144203938","170465246","26747882","855918"],"Wikipedia":["Benzthiazide"],"drugbank":["DB00562"],"chEBI":["3047"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201192","canonicalSmiles":"NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1","inchiKey":"YFGHCGITMMYXAQ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARMODAFINIL","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Armodafinil","Nuvigil"],"synonyms":["Armodafinil","CEP-10952","CEP-10953","CRL-40982"],"crossReferences":{"DailyMed":["armodafinil"],"Wikipedia":["Armodafinil"],"drugbank":["DB06413"],"chEBI":["77590"]},"count":19,"approvedIndications":["MONDO_0021107","EFO_0003888","EFO_0008568","EFO_0000614"],"linkedTargets":{"rows":["ENSG00000142319"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0003888","EFO_0000616","EFO_0005246","EFO_0006859","EFO_0005687","HP_0000726","MONDO_0007576","EFO_0008568","EFO_0001073","EFO_0004698","EFO_0003060","EFO_0000614","MONDO_0015917","EFO_0003885","MONDO_0002050","EFO_0000712","EFO_0003047","HP_0012378","MONDO_0043510","EFO_0003918","EFO_0000692","EFO_0005411","EFO_0003922"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 15 investigational indications."}
{"id":"CHEMBL1201199","canonicalSmiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"GFIJNRVAKGFPGQ-LIJARHBVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LEUPROLIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABBOTT-43818 FREE BASE","CKD-841","Leuprolide","Leuprorelin","NSC-377526","TAP-144 FREE BASE"],"crossReferences":{"DailyMed":["leuprolide%20acetate"],"Wikipedia":["Leuprorelin"],"drugbank":["DB00007"],"chEBI":["6427"]},"childChemblIds":["CHEMBL1200775"],"count":15,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0004248","EFO_0003869","EFO_0005204","Orphanet_64739","EFO_0001065","EFO_0009006","EFO_0000249","EFO_0000756","MONDO_0003061","MONDO_0007254","EFO_1001469","HP_0031217","EFO_0002950","HP_0100543","MONDO_0002146","MONDO_0000088","EFO_0000673","EFO_0000196","EFO_0000183","EFO_0000616","EFO_0000545","MONDO_0019165","EFO_0001073","EFO_0003843","MONDO_0008315","EFO_0000660","EFO_0001663","EFO_0000537","EFO_0000311","HP_0004322","EFO_0009029","EFO_0000731","EFO_0001378","MONDO_0024880","EFO_0003922"],"count":36},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for neoplasm and has 14 investigational indications."}
{"id":"CHEMBL1201335","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1","inchiKey":"ANGKOCUUWGHLCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRRONIUM","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glycopyrronium"],"crossReferences":{"DailyMed":["glycopyrrolate","glycopyrronium%20tosylate"],"Wikipedia":["Glycopyrronium_bromide"],"drugbank":["DB00986"]},"childChemblIds":["CHEMBL3707243","CHEMBL1201027"],"count":3,"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004210","EFO_0009512","EFO_0001645","EFO_0009516","EFO_0009267","MONDO_0001187","HP_0002110","HP_0006536","MONDO_0002050","EFO_0010282","EFO_0000270","HP_0000975","EFO_0000341","HP_0002307","GO_0007596"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 3 investigational indications."}
{"id":"CHEMBL1201404","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl","inchiKey":"QLIIKPVHVRXHRI-CXSFZGCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mometasone"],"crossReferences":{"drugbank":["DB00764"],"chEBI":["6970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201448","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ARDEPARIN SODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Normiflo"],"synonyms":["Ardeparin sodium","WY-90493 RD"],"crossReferences":{"Wikipedia":["Ardeparin_sodium"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL1201507","drugType":"Small molecule","blackBoxWarning":false,"name":"GLATIRAMER ACETATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Copaxone","Glatopa"],"synonyms":["COP-1","COPOLYMER-1","Glatiramer acetate"],"crossReferences":{"DailyMed":["glatiramer%20acetate"],"DrugCentral":["4880"],"Wikipedia":["Glatiramer_acetate"]},"count":10,"approvedIndications":["EFO_0003885"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for multiple sclerosis and has 9 investigational indications."}
{"id":"CHEMBL1201514","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGADEMASE BOVINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adagen"],"synonyms":["Pegademase bovine"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1990 and has 1 investigational indication."}
{"id":"CHEMBL1201546","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lente iletin ii"],"synonyms":["Insulin zinc susp purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201561","drugType":"Protein","blackBoxWarning":true,"name":"PEGINTERFERON ALFA-2B","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Peg-Intron","Pegintron"],"synonyms":["Peginterferon alfa-2b"],"crossReferences":{"DailyMed":["peginterferon%20alfa-2b"],"DrugCentral":["5164"],"Wikipedia":["Peginterferon_alfa-2b"]},"count":40,"approvedIndications":["EFO_0004220","EFO_0000389","EFO_0000756","EFO_0002617"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_1000403","EFO_0000637","MONDO_0019471","EFO_0000756","EFO_0000681","EFO_1000209","EFO_1001469","MONDO_0002087","EFO_0007304","MONDO_0016691","EFO_0000565","EFO_0002430","HP_0000083","MONDO_0002158","EFO_0000339","MONDO_0002974","EFO_0000389","EFO_0000182","EFO_0000326","EFO_0003047","EFO_0000707","EFO_0002617","EFO_0000479","HP_0012115","EFO_0000616","EFO_0006859","EFO_0000765","EFO_0001642","MONDO_0008170","EFO_0000180","Orphanet_636","EFO_0004197","EFO_0004243","EFO_0002429","EFO_0005221","EFO_0004239","EFO_0009708","EFO_0000311","EFO_0001422","EFO_0004220","MONDO_0100096","EFO_0000658","EFO_0000764","EFO_0000574","MONDO_0002367","EFO_0001378","MONDO_0018079"],"count":47},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 36 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201593","drugType":"Enzyme","blackBoxWarning":false,"name":"ALTEPLASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actilyse","Actilyse cathflo","Activase","Cathflo activase"],"synonyms":["Alteplase","Alteplase (genetical recombination)","Alteplase for injection","RT-PA","Tissue plasminogen activator alteplase"],"crossReferences":{"DailyMed":["alteplase"],"DrugCentral":["5141"]},"count":27,"approvedIndications":["EFO_0003966","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0000373","EFO_0000612","HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0009680","EFO_0003086","EFO_0003097","MONDO_0002679","EFO_0005669","EFO_1001154","EFO_0000373","MONDO_0001370","EFO_1000637","MONDO_0020673","EFO_0003913","EFO_0003966","EFO_0008585","EFO_1001375","EFO_0000544","EFO_0000712","MONDO_0005299","HP_0004419","EFO_0003030","MONDO_0002037","EFO_0000616","EFO_0000694","HP_0000016","HP_0002140","EFO_0009661","EFO_1001157","EFO_0000618","EFO_1001753","EFO_0000311","EFO_1001045","MP_0001914","EFO_0000713","MONDO_0100096","MONDO_0000831","EFO_0003827","EFO_0008583","EFO_0003907","EFO_0000612","HP_0004418"],"count":39},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 7 approved and 20 investigational indications."}
{"id":"CHEMBL1201610","drugType":"Protein","blackBoxWarning":false,"name":"CORTICOTROPIN","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acth","Acthar","Acthar gel","Adrenocorticotropic Hormone","Adrenocorticotropin","Adrenomone","Corticotropin","Cortigel","Cortrophin","H.p. acthar gel","Purified cortrophin gel"],"synonyms":["Corticotropin","Corticotropin, repository","Repository corticotropin"],"count":21,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000185231"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0007405","EFO_0000401","DOID_13406","EFO_0003778","MONDO_0002462","EFO_1000637","EFO_1001129","MONDO_0001718","EFO_0000474","EFO_0004254","EFO_0002690","EFO_0003884","EFO_0004255","EFO_0000253","EFO_0008522","Orphanet_797","EFO_0000685","EFO_0005761","EFO_0009449","EFO_1000906","EFO_0003821","HP_0000093","EFO_0003929","EFO_0004236","EFO_0009538","EFO_0000621","EFO_0000660","EFO_1001119","EFO_0003885","EFO_1001231","EFO_1000986","EFO_0008520","EFO_0000398","EFO_0000557"],"count":35},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for multiple sclerosis and has 20 investigational indications."}
{"id":"CHEMBL1213165","canonicalSmiles":"C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N21.[Na+]","inchiKey":"UGWJRRXTMKRYNK-VSLILLSYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLUTEGRAVIR SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1229211","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tivicay","Tivicay pd"],"synonyms":["Dolutegravir sodium","GSK1349572","GSK1349572A"],"crossReferences":{"DailyMed":["dolutegravir%20sodium"],"Wikipedia":["Dolutegravir"],"chEBI":["76007"]},"count":1,"approvedIndications":["EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for hiv infection."}
{"id":"CHEMBL1223","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"IYNDLOXRXUOGIU-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G POTASSIUM","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cilloral","Liquapen","Penicillin","Penicillin g potassium","Penicillin-2","Pentids","Pentids '200'","Pentids '250'","Pentids '400'","Pentids '800'","Pfizerpen","Pfizerpen g","Scotcil"],"synonyms":["Benzylpenicillin potassium","E705","NSC-131815","Penicillin G Potassium","Penicillin g potassium","Penicillin g potassium salt","Penicillin potassium g, crystalline","Penicillin-2","Pfizerpen","Pfizerpen G"],"crossReferences":{"DailyMed":["penicillin%20g%20potassium"],"PubChem":["56422871","855606"],"chEBI":["7963"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 10 investigational indications."}
{"id":"CHEMBL1229","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1","inchiKey":"VSZGPKBBMSAYNT-RRFJBIMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS 4104","GS-4071 ETHYL ESTER","GS-4104","GS4104","Oseltamivir","Oseltamivir Carboxylate","RO 640796","RO-64-0796","RO-640796","RO64-0796"],"crossReferences":{"DailyMed":["oseltamivir%20phosphate"],"Wikipedia":["Oseltamivir"],"drugbank":["DB00198"],"chEBI":["7798"]},"childChemblIds":["CHEMBL251990","CHEMBL1200340","CHEMBL3183419"],"count":8,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for viral disease and has 7 investigational indications."}
{"id":"CHEMBL1231055","canonicalSmiles":"CC(C)CCCCCCCCC(=O)N(C)[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)Cc2ccc(O)c(c2)-c2cc1ccc2O","inchiKey":"YFSXYWAZCKMYJN-JBBOGOJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARYLOMYCIN A2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arylomycin A2"],"crossReferences":{"drugbank":["DB01934"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231491","canonicalSmiles":"C[N+](C)(C)CC=O","inchiKey":"SXKNCCSPZDCRFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAINE ALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110846","90341389"],"drugbank":["DB04401"],"chEBI":["15710"]},"childChemblIds":["CHEMBL1256576"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233147","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XKMLYUALXHKNFT-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GTP","Guanosine Triphosphate"],"crossReferences":{"PubChem":["26756682"],"drugbank":["DB04137"],"chEBI":["15996"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235380","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(N)(=O)=O)cc4CC[C@H]3[C@@H]1CC(=O)N(Cc1cccnc1)C2=O","inchiKey":"LSJKARAMQNGZDF-YOEKFXIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235902","canonicalSmiles":"CCCCc1nc(N)[se]c1CCC","inchiKey":"DOUUMUUUWUAPPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235902","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01740"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236268","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)N(C=O)[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)cc1)CN2","inchiKey":"ZLOMJLIQXBKNHU-VJANTYMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236268","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02067"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123693","canonicalSmiles":"CCCCCC(C)N","inchiKey":"VSRBKQFNFZQRBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUAMINOHEPTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tuaminoheptane"],"crossReferences":{"Wikipedia":["Tuaminoheptane"],"drugbank":["DB13238"]},"childChemblIds":["CHEMBL1368028","CHEMBL3560769"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1237105","canonicalSmiles":"CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O.NC(CO)(CO)CO","inchiKey":"UMMADZJLZAPZAW-XOWPVRJPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBOPROST TROMETHAMINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237122","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hemabate"],"synonyms":["Carboprost trometanol","Carboprost tromethamine","U-32,921E","U-32921E"],"crossReferences":{"DailyMed":["carboprost%20tromethamine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1240967","canonicalSmiles":"CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1","inchiKey":"YPHDIMUXXABSSO-YTTGMZPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00610355","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF - 00610355","PF-610355","Pf-00610355"],"crossReferences":{"drugbank":["DB11871"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL126279","canonicalSmiles":"CCNC(C)Cc1ccc2c(c1)OCO2","inchiKey":"PVXVWWANJIWJOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126279","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01566"]},"childChemblIds":["CHEMBL3187218"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1272307","canonicalSmiles":"Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1","inchiKey":"ZJXIUGNEAIHSBI-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-649868","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK649868","SB-649868","Sb-649868"],"crossReferences":{"Wikipedia":["SB-649,868"],"drugbank":["DB14822"]},"childChemblIds":["CHEMBL3527302"],"count":2,"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_0008568","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1276308","canonicalSmiles":"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"VKHAHZOOUSRJNA-GCNJZUOMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIFEPRISTONE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Korlym","Mifegyne","Mifeprex"],"synonyms":["Mifepristone","RU 38486","RU 486","RU-38486","RU-486","RU486"],"crossReferences":{"DailyMed":["mifepristone"],"PubChem":["11533034","144204503","144212158","170465151","26752198","26752199","50104862","50104863","50124354","56424093","90341299"],"drugbank":["DB00834"],"chEBI":["50692"]},"count":36,"linkedTargets":{"rows":["ENSG00000082175","ENSG00000113580"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0002009","EFO_0001065","EFO_0000249","MONDO_0007254","EFO_0003768","EFO_1001110","MONDO_0002087","EFO_0002950","EFO_0003829","MONDO_0002046","MONDO_0002158","EFO_0000289","MONDO_0002050","EFO_0003099","EFO_0000673","EFO_0003047","Orphanet_2495","EFO_0005230","EFO_0000400","EFO_1001255","EFO_1001757","HP_0012076","MONDO_0008170","EFO_0001358","EFO_0003060","MONDO_0008315","EFO_0009784","EFO_0007430","EFO_0006861","EFO_0000731","EFO_0000764","MONDO_0011962","EFO_0000432","MONDO_0001572"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 36 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL14021","canonicalSmiles":"CCC(=O)O","inchiKey":"XBDQKXXYIPTUBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-280","E280","Ethanecarboxylic acid","FEMA NO. 2924","INS NO.280","INS-280","Propionic acid"],"crossReferences":{"PubChem":["251919690"],"Wikipedia":["Propanoic_acid"],"drugbank":["DB03766"],"chEBI":["30768"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1441961","canonicalSmiles":"CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1","inchiKey":"GFWRVVCDTLRWPK-KPKJPENVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFALCONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sofalcone"],"crossReferences":{"PubChem":["144205258","170466017","29215440"],"drugbank":["DB05197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL146032","canonicalSmiles":"CC(=O)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1","inchiKey":"VHZPUDNSVGRVMB-RXDLHWJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONAPRISAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY86-5044","Lonaprisan","ZK 230211","ZK-230211","Zk-230211"],"count":1,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1474889","canonicalSmiles":"CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1","inchiKey":"KVHHQGIIZCJATJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOBUTINOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2007},"tradeNames":[],"synonyms":["Clobutinol","Clobutinol hydrochloride","KAT 256 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["29215379"],"drugbank":["DB09004"]},"childChemblIds":["CHEMBL3183114"],"count":1,"approvedIndications":["HP_0012735"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for cough. It was withdrawn in European Union  in 2007 due to Cardiotoxicity."}
{"id":"CHEMBL1484857","canonicalSmiles":"O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"SKVLYVHULOWXTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINYLSULFATHIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Succinylsulfathiazole"],"crossReferences":{"PubChem":["11112259","144203951","170465721","855781"],"drugbank":["DB13580"],"chEBI":["9309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1500276","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1","inchiKey":"IQADUMSPOQKAAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXELADIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxeladin","Oxeladin citrate","Oxeladin tannate"],"crossReferences":{"PubChem":["26660767"],"Wikipedia":["Oxeladin"],"drugbank":["DB04822"]},"childChemblIds":["CHEMBL2354637"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1588","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.[Cl-]","inchiKey":"MYVIATVLJGTBFV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1547","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxin","Vitamin B 1"],"synonyms":["Betamin","Thiamine","Thiamine (vit b1)"],"crossReferences":{"PubChem":["50085978"],"Wikipedia":["Thiamine"],"chEBI":["33283"]},"count":2,"approvedIndications":["EFO_0003884","EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for anemia (phenotype) and chronic kidney disease."}
{"id":"CHEMBL1650619","canonicalSmiles":"On1ccccc1=S","inchiKey":"YBBJKCMMCRQZMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["36578"]},"childChemblIds":["CHEMBL3392049","CHEMBL2105351"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1697833","canonicalSmiles":"CC(C)(N)Cc1ccccc1Cl","inchiKey":"HXCXASJHZQXCKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORTERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clortermine"],"crossReferences":{"PubChem":["170466437"],"Wikipedia":["Clortermine"],"drugbank":["DB01527"]},"childChemblIds":["CHEMBL2107635"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743032","drugType":"Antibody","blackBoxWarning":false,"name":"INTETUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO 095","CNTO 95","CNTO-095","CNTO-95","Intetumumab"],"count":2,"linkedTargets":{"rows":["ENSG00000138448"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000673"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743068","drugType":"Antibody","blackBoxWarning":false,"name":"SECUKINUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AIN-457","AIN457","AIN457A","Secukinumab"],"crossReferences":{"DailyMed":["secukinumab"],"DrugCentral":["4934"]},"count":25,"approvedIndications":["EFO_0000676","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_1001494","EFO_0003780","EFO_0003778","EFO_0000274","EFO_0000540","EFO_0008518","EFO_0002506","EFO_0000676","HP_0000999","EFO_0000685","EFO_0005761","EFO_1000906","EFO_0003898","EFO_0003929","MONDO_0019558","EFO_0000384","EFO_1001209","EFO_1000760","EFO_1001231","EFO_0003885","MP_0001845","EFO_0004192","EFO_1000738","EFO_0000270","EFO_0001359","Orphanet_2897","EFO_0000706","EFO_1001434","EFO_0009856"],"count":30},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for immune system disease and psoriasis and has 23 investigational indications."}
{"id":"CHEMBL178130","canonicalSmiles":"CCc1cc(-c2n[nH]c(C(=O)O)c2-c2ccc3c(c2)OCO3)c(O)cc1O","inchiKey":"LCTWZJKHOGKNMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178130","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02840"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1834657","canonicalSmiles":"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O","inchiKey":"GUQNHCGYHLSITB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INFIGRATINIB PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1852688","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGJ-398 phosphate","Infigratinib phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1898907","canonicalSmiles":"Cc1cnc(NC(=O)C2=C([O-])c3ccccc3S(=O)(=O)N2C)s1.O.[Na+]","inchiKey":"IZBZAOZGNNQKPJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1898907","maximumClinicalTrialPhase":0,"parentId":"CHEMBL599","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["46500410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908315","canonicalSmiles":"CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)OC","inchiKey":"KYBOHGVERHWSSV-VNIVIJDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMEPROST","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cervagem"],"synonyms":["Gemeprost","SC-37681"],"crossReferences":{"drugbank":["DB08964"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1908917","canonicalSmiles":"N[C@]1(C(=O)O)C[C@@H](F)C1","inchiKey":"NTEDWGYJNHZKQW-IWLYVCSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1908917","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15237"]},"childChemblIds":["CHEMBL254468"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1914653","canonicalSmiles":"Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1","inchiKey":"SYYMNUFXRFAELA-BTQNPOSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PKI-166","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1963502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PKI-166"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL192894","canonicalSmiles":"COc1ccc(-c2c(-c3ccc(O)cc3O)n[nH]c2C)cc1","inchiKey":"GSBFARPNIZUMHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL192894","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137276075"],"drugbank":["DB08356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196003","canonicalSmiles":"CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"QFFCYTLOTYIJMR-XMGTWHOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMEGESTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Promegestone"],"crossReferences":{"drugbank":["DB13602"],"chEBI":["73390"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048028","canonicalSmiles":"CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1","inchiKey":"JFOZKMSJYSPYLN-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFITEGRAST","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xiidra"],"synonyms":["Lifitegrast","SAR 1118","SAR-1118","SHP-606","SHP606"],"crossReferences":{"DailyMed":["lifitegrast"],"drugbank":["DB11611"]},"childChemblIds":["CHEMBL2048409","CHEMBL2048410"],"count":3,"approvedIndications":["EFO_0003966","EFO_1000906"],"linkedTargets":{"rows":["ENSG00000005844","ENSG00000160255"],"count":2},"linkedDiseases":{"rows":["EFO_0003966","EFO_1000906","EFO_0007141","EFO_0009321"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for dry eye syndrome and eye disease and has 1 investigational indication."}
{"id":"CHEMBL2105677","canonicalSmiles":"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"OQXMMAQEMJUIQM-LVEZLNDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARACATINIB DIFUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL217092","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD0530 DIFUMARATE","Saracatinib difumarate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105801","canonicalSmiles":"CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O.Cl","inchiKey":"KXNZMBFOWDNCRU-QVMZSJACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELGOSIVIR HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110737","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Celgosivir hydrochloride","MDL 28,574A","MDL-28574A"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106068","canonicalSmiles":"CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl","inchiKey":"IJFUJIFSUKPWCZ-SQMFDTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRASENTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL9194","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-127722","A-147627.1","ABBOT-147627","ABT-627","Atrasentan hydrochloride"],"count":6,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0008170","MONDO_0002367","MONDO_0002087","MONDO_0024880","MONDO_0008315","EFO_1000158"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2106124","canonicalSmiles":"O=P([O-])([O-])OCC(O)CO.[Ca+2]","inchiKey":"IWIRHXNCFWGFJE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLYCEROPHOSPHATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium glycerinophosphate","Calcium glycerophosphate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106922","canonicalSmiles":"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.O=C(O)/C=C\\C(=O)O","inchiKey":"XYGVIBXOJOOCFR-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIDAZOLAM MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dormicum"],"synonyms":["Midazolam maleate","RO 21-3981/001"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107308","canonicalSmiles":"COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC.Cl.O.O.O","inchiKey":"NPTDXIXCQCFGKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOTIAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2107723","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acotiamide hydrochloride","Acotiamide hydrochloride hydrate","Acotiamide hydrochloride trihydrate","YM-443","YM443","Z-338"],"count":1,"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0008533"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107358","canonicalSmiles":"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\\c1[nH]c(C)cc1C.CS(=O)(=O)O","inchiKey":"ZFKXDVMHNXPEIY-PEZBNFGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBATOCLAX MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL408194","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"count":14,"linkedTargets":{"rows":["ENSG00000140379","ENSG00000171552","ENSG00000258643","ENSG00000171791","ENSG00000137875","ENSG00000143384","ENSG00000129473"],"count":7},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0044903","MONDO_0001023","EFO_0000095","EFO_0001642","MONDO_0008903","EFO_0000403","EFO_0000702","EFO_0001378","EFO_1001469","EFO_0000183","MONDO_0018906","EFO_0002617"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2107465","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCNC[C@@H]1OC","inchiKey":"OMLDMGPCWMBPAN-YPMHNXCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICALOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ticalopride"],"crossReferences":{"drugbank":["DB06422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107576","canonicalSmiles":"CNCCON=c1c2ccccc2ccc2ccccc12","inchiKey":"SEDQWOMFMIJKCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMEXIPTILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demexiptiline"],"crossReferences":{"drugbank":["DB08998"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107863","drugType":"Unknown","blackBoxWarning":false,"name":"RINDOPEPIMUT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-110","PF-04948568","PF-04948568 (FORMERLY CDX-110)","Rindopepimut"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108074","drugType":"Enzyme","blackBoxWarning":false,"name":"PANCRELIPASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accelerase","Cotazym","Cotazym-s","Creon","Entolase","Ilozyme","Ku-zyme hp","Pancrease","Viokase","Zymase"],"synonyms":["Lipancreatin","Pancrelipase","Pancrelipase (amylase;lipase;protease)"],"crossReferences":{"DailyMed":["pancrelipase%20(amylase;lipase;protease)"],"DrugCentral":["5161"]},"count":6,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 investigational indications."}
{"id":"CHEMBL2108200","drugType":"Unknown","blackBoxWarning":false,"name":"DIMETHICONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conotrane","Cymex","Hedrin","Johnson's","Rikospray","Sentry dimethicone","Sentry dimethicone dispension","Siopel","Sprilon","Superderm","Vasogen"],"synonyms":["Dimethicone","Dimeticone","Dimeticone ","E-900A","INS NO.900A","INS-900A"],"crossReferences":{"DrugCentral":["3152"]},"count":2,"approvedIndications":["EFO_0001067"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for parasitic infection and has 1 investigational indication."}
{"id":"CHEMBL2108201","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRANOMER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Debrisan"],"synonyms":["Dextranomer"],"count":1,"approvedIndications":["HP_0200042"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL2108221","drugType":"Unknown","blackBoxWarning":false,"name":"ALOE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloe","B2348"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108339","drugType":"Protein","blackBoxWarning":false,"name":"EGAPTIVON PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC-1779","ARC1779","Arc1779","Egaptivon pegol"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108535","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYNOXYLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anaflex"],"synonyms":["Oxymethylene urea","Polynoxylin"],"crossReferences":{"DrugCentral":["4693"]},"count":1,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL2108730","drugType":"Antibody","blackBoxWarning":true,"name":"SARILUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kevzara"],"synonyms":["REG-N88","REGN-88","REGN88","SAR-153191","SAR153191","Sarilumab"],"crossReferences":{"DailyMed":["sarilumab"]},"count":11,"approvedIndications":["EFO_0000685","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000685","EFO_0003898","MONDO_0016586","EFO_0000540","EFO_0002609","EFO_0000311","EFO_0003106","EFO_1001209","EFO_0008518","EFO_1001231","MONDO_0100096","EFO_1001361","EFO_0007328"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for rheumatoid arthritis and immune system disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108778","drugType":"Unknown","blackBoxWarning":false,"name":"POLIOVIRUS VACCINE LIVE ORAL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orimune"],"synonyms":["Poliovirus vaccine live oral"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109103","drugType":"Antibody","blackBoxWarning":false,"name":"BERTILIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bertilimumab","CAT-213","ICO-008"],"count":2,"linkedTargets":{"rows":["ENSG00000172156"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0007187"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109257","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-1C11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-1C11"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109264","drugType":"Antibody","blackBoxWarning":false,"name":"SOLITOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MT110","Solitomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109395","drugType":"Antibody","blackBoxWarning":false,"name":"ZATUXIMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zatuximab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111078","canonicalSmiles":"Cc1nc(NS(=O)(=O)c2ccc(N)cc2)nc(C)c1Br","inchiKey":"KWXCNODTHBHSIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFABROMOMETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206282"],"drugbank":["DB11547"]},"childChemblIds":["CHEMBL3989656"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL216697","canonicalSmiles":"CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1","inchiKey":"AINVOEOJEKKMKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216697","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2177390","canonicalSmiles":"CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1","inchiKey":"GRZXWCHAXNAUHY-NSISKUIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPATASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0068","Ipatasertib","RG-7440","RG7440","Rg-7440"],"crossReferences":{"drugbank":["DB11743"]},"count":10,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0003869","EFO_0003893","EFO_0005537","MONDO_0011962","EFO_0000196","MONDO_0007254","EFO_0000305","MONDO_0008315","EFO_0003060","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL229128","canonicalSmiles":"Cc1ccccc1OCC(O)CO","inchiKey":"JWDYCNIAQWPBHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENESIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decontractyl","Tolserol"],"synonyms":["Cresoxydiol","Mephenesin"],"crossReferences":{"PubChem":["144204909","170466586","26748509"],"Wikipedia":["Mephenesin"],"drugbank":["DB13583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2355051","canonicalSmiles":"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1","inchiKey":"GKIRPKYJQBWNGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMIPHENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clomifene","Clomiphene"],"crossReferences":{"DailyMed":["clomiphene%20citrate"],"PubChem":["144206661","170464951"],"drugbank":["DB00882"],"chEBI":["3752"]},"childChemblIds":["CHEMBL3185958"],"count":11,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_1001485","EFO_0000512","EFO_0000731","EFO_0000279","EFO_0008560","MONDO_0002775","EFO_0001073","EFO_0000660","MONDO_0018555","EFO_0002950"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 11 investigational indications."}
{"id":"CHEMBL2368924","canonicalSmiles":"CS(=O)(=O)O.O.O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12","inchiKey":"QTFFGPOXNNGTGZ-LIFGOUTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASETRON MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2368925","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anzemet"],"synonyms":["Dolasetron mesilate","Dolasetron mesylate","MDL 73,147EF","MDL-73147EF"],"crossReferences":{"DailyMed":["dolasetron%20mesylate"]},"count":2,"approvedIndications":["HP_0002017","EFO_0004888"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["HP_0002017","EFO_0004888"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for nausea and vomiting and post operative nausea and vomiting."}
{"id":"CHEMBL24038","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)O","inchiKey":"WMUIIGVAWPWQAW-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAGAGLITAZAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ragaglitazar"],"crossReferences":{"drugbank":["DB07675"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL240719","canonicalSmiles":"Cc1ccccc1CC(=O)Nc1cc(C)c(S(=O)(=O)NCC(=O)O)c(C)c1","inchiKey":"CJKKMQCZOLCXAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240719","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24231","canonicalSmiles":"O=[N+]([O-])c1ccc(OP(=O)(O)O)cc1","inchiKey":"XZKIHKMTEMTJQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-NITROPHENYLPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Nitrophenyl Dihydrogen Phosphate","4-Nitrophenyl Phosphate","P-Nitrophenylphosphate"],"crossReferences":{"Wikipedia":["Para-Nitrophenylphosphate"],"drugbank":["DB04214"],"chEBI":["17440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL256705","canonicalSmiles":"C[C@@H]1CC(=O)c2c(ccc3c2C(=O)c2cccc(O)c2C3=O)C1","inchiKey":"ZAWXOCUFQSQDJS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCHROMYCINONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J655.169F","Ochromycinone","STA-21"],"crossReferences":{"drugbank":["DB15644"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL257705","canonicalSmiles":"Cc1cc(-c2c(-c3ccccc3)c3cc(Cl)ccc3[nH]c2=O)on1","inchiKey":"QINNOQKHPLWGBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257705","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261244","canonicalSmiles":"CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21.[Na+].[Na+]","inchiKey":"MKQKPLQMNCXTJE-VEZQGTPESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"REGRELOR DISODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1162175","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INS-50589","INS50589","Regrelor disodium"],"count":1,"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL267744","canonicalSmiles":"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl","inchiKey":"AGHANLSBXUWXTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICRYNAFEN","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Hepatotoxicity"],"year":1980},"tradeNames":["Selacryn"],"synonyms":["SK&F 62698","Ticrynafen","Tienilic acid"],"crossReferences":{"PubChem":["144205234","144205235","29215401","29215402"],"Wikipedia":["Tienilic_acid"],"drugbank":["DB04831"],"chEBI":["9590"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for cardiovascular disease. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1980 due to Hepatotoxicity."}
{"id":"CHEMBL267777","canonicalSmiles":"Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"JUQLTPCYUFPYKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tiserton"],"synonyms":["R 55,667","R-55667","Ritanserin"],"crossReferences":{"PubChem":["11111716","144203802","170466554","50100336","50104035","50104036","50104037","50123110","56423112","85231205","855736","90340705"],"drugbank":["DB12693"],"chEBI":["64195"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL27","canonicalSmiles":"CC(C)NCC(O)COc1cccc2ccccc12","inchiKey":"AQHHHDLHHXJYJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPRANOLOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AY-64043-","Inderal","Inderide-40/25","Inderide-80/25","Propranolol"],"crossReferences":{"DailyMed":["propranolol%20hydrochloride"],"PubChem":["124881056","26751802","26755283","50104497","90341556"],"Wikipedia":["Propranolol"],"drugbank":["DB00571"],"chEBI":["8499"]},"childChemblIds":["CHEMBL1671"],"count":61,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0002610","EFO_0004262","EFO_0004280","MONDO_0002009","EFO_0000275","EFO_0000756","EFO_0000681","EFO_0004278","EFO_0003768","EFO_1001917","EFO_0009322","Orphanet_79383","EFO_1000911","HP_0004755","EFO_0000389","EFO_0000182","EFO_0005295","HP_0003419","EFO_1000802","EFO_0003756","EFO_0005296","EFO_0003821","EFO_1001466","MONDO_0002363","EFO_0009516","EFO_1001968","Orphanet_558","EFO_0000666","EFO_0001663","HP_0001279","EFO_0000546","EFO_0001422","EFO_0000270","EFO_0001359","EFO_0009545","EFO_0001378","EFO_0000341","HP_0001943","EFO_0001360","EFO_0003108","EFO_1001158","EFO_0005251","EFO_0003086","EFO_0005687","Orphanet_232","EFO_0005252","MONDO_0007254","Orphanet_221061","MONDO_0016236","EFO_0003882","MONDO_0001187","MONDO_0001056","EFO_1000218","EFO_0003968","EFO_0003860","EFO_1001375","HP_0030834","EFO_0000712","EFO_1000645","EFO_0004242","EFO_0005230","MONDO_0000820","EFO_1000635","HP_0001541","EFO_0004319","HP_0001337","EFO_0004329","EFO_0001358","EFO_0000319","EFO_1001884","EFO_0003843","HP_0002315","EFO_0009189","EFO_0000537","EFO_0000311","EFO_0001072","Orphanet_230","EFO_0004287","Orphanet_774","EFO_0004142","EFO_0000612","MONDO_0043510","EFO_0003918"],"count":84},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 60 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL274467","canonicalSmiles":"CC(=O)c1ccccc1","inchiKey":"KWOLFJPFCHCOCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOPHENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetophenone"],"crossReferences":{"PubChem":["144209620"],"Wikipedia":["Acetophenone"],"drugbank":["DB04619"],"chEBI":["27632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286204","canonicalSmiles":"O=C(O)c1cccnc1C(=O)O","inchiKey":"GJAWHXHKYYXBSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridine-2,3-Dicarboxylic Acid","Quinolinic Acid"],"crossReferences":{"PubChem":["11111698","11113416","124881252","144212368","26747101","50104349","57260132","90341105"],"Wikipedia":["Quinolinic_acid"],"drugbank":["DB01796"],"chEBI":["16675"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290578","canonicalSmiles":"CC(C)OC(=O)Nc1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"QZWHWHNCPFEXLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Camdan"],"synonyms":["Cambendazole"],"crossReferences":{"PubChem":["144206277","50125821"],"drugbank":["DB11380"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295467","canonicalSmiles":"CNCCC(Oc1ccccc1OC)c1ccccc1","inchiKey":"ITJNARMNRKSWTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NISOXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPOUND 89218","LY-94939","Nisoxetine"],"crossReferences":{"PubChem":["104171195","144203754","170466483","26752034","50104694","90341689"],"Wikipedia":["Nisoxetine"],"drugbank":["DB09186"],"chEBI":["73410"]},"childChemblIds":["CHEMBL1628648","CHEMBL1256695"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296323","canonicalSmiles":"C[C@](O)(CBr)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"QDSWNDMHSBZXKX-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL296323","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07454"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30424","canonicalSmiles":"Cc1cccc2nc3cccc(C(=O)NCCNCCNCCNC(=O)c4cccc5nc6cccc(C)c6nc45)c3nc12","inchiKey":"SFOADSRLCHRTKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL30424","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06364"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137310","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341.Cl","inchiKey":"VVCUIDHKAHHSAN-JJHQWJQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZHYDROCODONE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3137321","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzhydrocodone hydrochloride","KP201"],"crossReferences":{"DailyMed":["benzhydrocodone%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for pain."}
{"id":"CHEMBL3137338","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ASVASIRAN SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALN-RSV-01","ALN-RSV01","Asvasiran sodium"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL318516","canonicalSmiles":"NCCCCCCNCCCCCCN","inchiKey":"MRNZSTMRDWRNNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL318516","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207244"],"drugbank":["DB04684"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186761","canonicalSmiles":"CC(=O)O[C@@H]1C[C@@H]2CC[C@@]1(C)C2(C)C","inchiKey":"KGEKLUUHTZCSIP-HOSYDEDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186761","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205151","144212050"],"drugbank":["DB14665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186768","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"YGULWPYYGQCFMP-CEAXSRTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186768","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204338","144207077","170464652"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186849","canonicalSmiles":"O=C(O)CCCCC(CCSCc1ccccc1)SCc1ccccc1","inchiKey":"ZYRLHJIMTROTBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPI 613","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI 613","Cpi 613","Devimistat"],"crossReferences":{"PubChem":["174007465"],"drugbank":["DB12109"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3392303","canonicalSmiles":"CC(=O)O.COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O","inchiKey":"NVDQULLLJIPDRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3392303","maximumClinicalTrialPhase":0,"parentId":"CHEMBL119","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544917","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O","inchiKey":"GIBQQARAXHVEGD-BSOLPCOYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RAPASTINEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLYX-13","Rapastinel"],"crossReferences":{"drugbank":["DB11801"]},"count":2,"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0004242"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545014","drugType":"Small molecule","blackBoxWarning":false,"name":"AM-461","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Am-461"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545090","drugType":"Small molecule","blackBoxWarning":false,"name":"RXDX-103","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rxdx-103"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545135","drugType":"Small molecule","blackBoxWarning":false,"name":"NV-128","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nv-128"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545186","canonicalSmiles":"Cc1cc2c(CCc3sc(-c4ccc(C(F)(F)F)cc4)nc3C(C)C)noc2cc1OCC(=O)O","inchiKey":"WWKYLBGQYALEDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FONADELPAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fonadelpar","NPS-005","SJP-0035"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545314","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)C(C)C","inchiKey":"ZUJBBVJXXYRPFS-DYKIIFRCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DUSQUETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dusquetide","IMX-942","SGX-94","SGX-942","SGX94","SGX942","Sgx942"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545355","canonicalSmiles":"COc1ccc(C2=C(Cc3ccc(OCCN4CCCCC4)cc3)c3ccc(O)cc3OC2)cc1","inchiKey":"ZUDXUNPSRMREOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHF4227","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chf4227"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545431","drugType":"Small molecule","blackBoxWarning":false,"name":"HMN-214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hmn-214","IVX-214"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707231","canonicalSmiles":"C[C@]12C[C@H](Cl)[C@@]3(Cl)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"VTWKPILBIUBMDS-OTJLYDAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCLOROLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluclorolone"],"crossReferences":{"drugbank":["DB13856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707338","canonicalSmiles":"Cc1ncc(COP(=O)([O-])O)c(C=O)c1O.NC(=O)CC[C@H](N)C(=O)[O-].[Mg+2]","inchiKey":"HFAKVRNAKYBCSN-RJXKWAGSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PYRIDOXAL 5-PHOSPHATE GLUTAMATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707339","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium pyridoxal 5-phosphate glutamate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3765414","canonicalSmiles":"C[N+](C)(C)CCO.O=C([O-])c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O","inchiKey":"KPEHUOWGTSRCIC-ANVLNOONSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3765414","maximumClinicalTrialPhase":0,"parentId":"CHEMBL421","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3828009","canonicalSmiles":"C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl","inchiKey":"GKJCVYLDJWTWQU-CXLRFSCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3828009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13022"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833334","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.COc1ccc2c3c1OC1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.Cl.Cl.Cl","inchiKey":"LGFMXOTUSSVQJV-LYAFVJFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAPAVERETUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833406","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnopon-scopolamine"],"synonyms":["Papaveretum"],"count":1,"approvedIndications":["EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL38912","canonicalSmiles":"C[C@@H](NC(=O)c1cc(F)ccc1O)c1ccc(Br)cc1","inchiKey":"KFTNEILVDDUXGR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL38912","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02880"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989563","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.O.O.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"LDMPZNTVIGIREC-CZEDPBFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE BITARTRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-97238","Nicotine bitartrate","Nicotine bitartrate dihydrate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989869","canonicalSmiles":"CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"KYJWUPZPSXZEPG-NTISSMGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMBRALISIB TOSYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3948730","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RP-5307","TGR-1202","TGR-1202 (4-METHYLBENZENESULFONATE)","Tgr-1202","Umbralisib tosylate"],"count":14,"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0044903","EFO_0000403","EFO_1000657","Orphanet_44890","MONDO_0007576","EFO_1001469","EFO_0002429","EFO_1001951","EFO_0000211","MONDO_0001056","EFO_0000095","MONDO_0018906","EFO_0000183"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL3989940","canonicalSmiles":"[2H]C([2H])([2H])Oc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C([2H])([2H])[2H])CC3","inchiKey":"MKXZASYAUGDDCJ-QNNIAVNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUDEXTROMETHORPHAN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL52440","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C100003","CTP-786","Deudextromethorphan","d6-DM"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989954","canonicalSmiles":"C=C1CC[C@H]2[C@H](CN)[C@@H]([C@@]3(C)CC[C@H](O)C[C@@H]3CO)CC[C@]12C","inchiKey":"MDEJTPWQNNMAQF-BVMLLJBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSIPTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AQX-1125","AQX-1125 free base","Aqx-1125","Rosiptor"],"crossReferences":{"drugbank":["DB13012"]},"childChemblIds":["CHEMBL3989953"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990014","drugType":"Antibody","blackBoxWarning":false,"name":"MIRIKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3074828","LY3074828","Mirikizumab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL399530","canonicalSmiles":"CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O","inchiKey":"OWPMENVYXDJDOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CCT018159","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCT018159"],"crossReferences":{"PubChem":["103905505","174006740","26755036"],"drugbank":["DB07594"],"chEBI":["41656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406652","canonicalSmiles":"O=C(O)c1cccc2c(-c3ccccc3)c(-c3ccccc3)[nH]c12","inchiKey":"OLUDUXWVPIEHDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406652","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24819975"],"drugbank":["DB08709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4105584","canonicalSmiles":"COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1[C@H]3CC[C@@H]1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21","inchiKey":"ZTTKEBYSXUCBSE-QDFUAKMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4105584","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12225"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4175954","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12.O.O.O","inchiKey":"CTUAQTBUVLKNDJ-OBZXMJSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4175954","maximumClinicalTrialPhase":0,"parentId":"CHEMBL127","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420762","canonicalSmiles":"Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1","inchiKey":"WRNXUQJJCIZICJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOZAVAPTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mozavaptan"],"crossReferences":{"PubChem":["170466304"],"Wikipedia":["Mozavaptan"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL421","canonicalSmiles":"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O","inchiKey":"NCEXYHBECQHGNR-QZQOTICOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFASALAZINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azulfidine","Azulfidine EN","Azulfidine en-tabs","Colizine","S.a.s.","S.a.s.-500","Salazopyrin","Salazopyrin e.c.","Salazopyrin-en","Salazosulfapyridine","Salicylazosulfapyridine","Sulfasalazine","Ucine"],"synonyms":["Azulfidine","NSC-203730","NSC-667219","SAS-500","Salazosulfapyridine","Salicylazosulfapyridine","Sulfasalazine","Sulphasalazine"],"crossReferences":{"DailyMed":["sulfasalazine"],"PubChem":["144204588","144208437","144210859","170464716","17389737","26747277"],"TG-GATEs":["34"],"Wikipedia":["Sulfasalazine"],"drugbank":["DB00795"],"chEBI":["9334"]},"childChemblIds":["CHEMBL3765414","CHEMBL2311115"],"count":9,"approvedIndications":["EFO_0000685","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001361","EFO_0004268","EFO_0006911","EFO_0003898","EFO_0003778","EFO_0004149","EFO_0003102","HP_0004798","MONDO_0004565","EFO_0002609","EFO_0000519"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for juvenile idiopathic arthritis and rheumatoid arthritis and has 7 investigational indications."}
{"id":"CHEMBL4250860","canonicalSmiles":"CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(-c3cnc(C)nc3)cc12","inchiKey":"PIBARDGJJAGJAJ-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANICOPAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-0144471","ACH-4471","Ach-0144471","Danicopan"],"crossReferences":{"drugbank":["DB15401"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297226","drugType":"Unknown","blackBoxWarning":false,"name":"CANERPATUREV","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Canerpaturev","HF10","TBI-1401"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297292","canonicalSmiles":"C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1.[Cl-]","inchiKey":"VALRCWBOFWDEDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-17166864","maximumClinicalTrialPhase":2,"parentId":"CHEMBL397647","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-17166864","Jnj-17166864"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297388","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N","inchiKey":"WUBKGTSFJSEIEM-NSHBDUGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-870086","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW870086","GW870086X","Gw-870086","Gw870086x"],"crossReferences":{"drugbank":["DB12322"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297448","canonicalSmiles":"c1ccc(-c2cc(-c3ccncc3)c(N3CCN(c4ncccn4)CC3)nn2)cc1","inchiKey":"ZPJGUEPHFXPAQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TT-301","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MW-01-6-189WH","MW-189","MW01-6-189WH","TT301","Tt-301","Tt301"],"crossReferences":{"drugbank":["DB12899"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297506","canonicalSmiles":"FC(F)(F)c1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1","inchiKey":"FUAHXHWSMYFWGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPACONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dapaconazole"],"crossReferences":{"drugbank":["DB11985"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297511","canonicalSmiles":"N[C@@H](CCS(=O)(=O)O)CSSC[C@@H](N)CCS(=O)(=O)O","inchiKey":"HJPXZXVKLGEMGP-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRIBASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firibastat","QGC001","Qgc001","RB-150"],"crossReferences":{"drugbank":["DB13107"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297557","drugType":"Unknown","blackBoxWarning":false,"name":"MICROCRYSTALLINE CELLULOSE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cellulose","Cellulose microcrystalline","Microcrystalline cellulose"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297582","canonicalSmiles":"O=C(CCCCCCC(=O)Nc1ccc(CN[C@H](C(=O)OC2CCCC2)c2ccccc2)cc1)NO","inchiKey":"GLNWREBYRLDPQP-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEFINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tefinostat"],"crossReferences":{"drugbank":["DB15321"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297619","canonicalSmiles":"O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12","inchiKey":"NALAUGMPMIVAOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENARODUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enarodustat","JTZ-951","Jtz-951"],"crossReferences":{"drugbank":["DB14985"]},"childChemblIds":["CHEMBL4166742"],"count":1,"linkedTargets":{"rows":["ENSG00000135766"],"count":1},"linkedDiseases":{"rows":["EFO_0003884"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297633","canonicalSmiles":"CC(C)OC(=O)CCC[C@H]1CC[C@H]2[C@H](C[C@@H](O)[C@@H]2/C=C/[C@@H](O)COc2cc(F)ccc2F)OC1","inchiKey":"BKVUSNOUTQMSBE-XCMGCKIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPETAPROST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DE-126","ONO-9054","Ono-9054","Sepetaprost"],"crossReferences":{"drugbank":["DB12043"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297636","canonicalSmiles":"C/C=C\\C[C@@H](C/C=C\\NC(=O)[C@@H](NC(=O)/C=C\\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O","inchiKey":"IEKGSKLKBICCHQ-BDOJOPHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLOCABULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.348.355D","PM-060184","PM060184","Plocabulin","Pm 060184","Pm060184"],"crossReferences":{"drugbank":["DB13137"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297861","drugType":"Antibody","blackBoxWarning":false,"name":"NEIHULIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abgn-168h","Neihulizumab"],"count":5,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297878","drugType":"Unknown","blackBoxWarning":false,"name":"AK-002","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-002","AK002","Ak-002","Ak002"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298014","drugType":"Unknown","blackBoxWarning":false,"name":"LSZ-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSZ-102","LSZ102","Lsz-102","Lsz102"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298169","canonicalSmiles":"O=C(O)c1cc(F)c2nc(N3[C@H]4CC[C@@H]3C[C@H](OCc3c(-c5ccccc5OC(F)(F)F)noc3C3CC3)C4)sc2c1","inchiKey":"VYLOOGHLKSNNEK-PIIMJCKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPIFEXOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LJN-452","LJN452","NVP-LJN452-NXA","Tropifexor"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298173","canonicalSmiles":"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"NWYDRHSNEATNRI-SQQVDAMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTIRACICLIB CITRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1944698","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG02 citrate","Zotiraciclib citrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL430879","canonicalSmiles":"N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)cc2)n2cnnc2)cc1","inchiKey":"WEXGHQDVDVWOIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL430879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04601"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL431770","canonicalSmiles":"CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O","inchiKey":"IQVRBWUUXZMOPW-PKNBQFBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISTRADEFYLLINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nourianz"],"synonyms":["Istradefylline","KW-6002"],"crossReferences":{"DailyMed":["istradefylline"],"PubChem":["170466116"],"Wikipedia":["Istradefylline"],"drugbank":["DB11757"]},"count":3,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","EFO_0002508","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for parkinson's disease and has 2 investigational indications."}
{"id":"CHEMBL434025","canonicalSmiles":"O=C(NCCOCCOCCNC(=O)c1cc2cc(Cl)ccc2[nH]1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"MWWXABBBAPKJDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL434025","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455271","canonicalSmiles":"NS(=O)(=O)c1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"KGMVTZZDGKDTEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455271","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594440","canonicalSmiles":"Fc1cc(F)c2c(c1)C[C@@H](n1c(CCNCc3ccccc3)c[nH]c1=S)CO2","inchiKey":"ZSSLCFLHEFXANG-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZAMICASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zamicastat"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594491","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"REMLARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRG-201","Mrg-201","Remlarsen"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594517","drugType":"Antibody","blackBoxWarning":false,"name":"GILORALIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-927","Abbv-927","Giloralimab","PR-1614645"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594532","drugType":"Antibody","blackBoxWarning":false,"name":"AVIZAKIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avizakimab","BOS-161721","BOS161721","Bos161721"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594539","drugType":"Unknown","blackBoxWarning":false,"name":"BOTULINUM TOXIN TYPE E","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Botulinum toxin type e","EB-001","Eb-001"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL460258","canonicalSmiles":"C[C@@H]1C[C@@H]2C(=C3CCC(=O)C=C31)[C@@H](c1ccc(N(C)C)cc1)C[C@@]1(C)[C@H]2CC[C@@]12CCCO2","inchiKey":"HFDGABTZPISMDD-IEVXGSBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460258","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15585"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46293","canonicalSmiles":"O=CNCc1ccccc1","inchiKey":"IIBOGKHTXBPGEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Benzyl-Formamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Benzyl-Formamide"],"crossReferences":{"drugbank":["DB02481"],"chEBI":["41117"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL481122","canonicalSmiles":"Br.Br.Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1","inchiKey":"ACPWZKZFDFBALX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOCETINOSTAT DIHYDROBROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL272980","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mocetinostat dihydrobromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483849","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N","inchiKey":"NOTGFIUVDGNKRI-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483849","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["AICA_ribonucleotide"],"drugbank":["DB01700"],"chEBI":["18406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506569","canonicalSmiles":"CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"JAYAGJDXJIDEKI-PTGWOZRBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANATOSIDE C","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cedilanid"],"synonyms":["Lanatoside c"],"crossReferences":{"PubChem":["144204914"],"Wikipedia":["Lanatoside_C"],"drugbank":["DB13467"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL509282","canonicalSmiles":"C=CCC(C(=O)NC(N)=O)C(C)C","inchiKey":"KSUUMAWCGDNLFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRONAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apronal","Sedormid"],"crossReferences":{"Wikipedia":["Apronal"],"drugbank":["DB13221"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL534499","canonicalSmiles":"CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1.Cl","inchiKey":"CFPJFUWDJOGWFR-GNAFDRTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL534499","maximumClinicalTrialPhase":0,"parentId":"CHEMBL402548","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542","canonicalSmiles":"Nc1ccc(C(=O)O)cc1","inchiKey":"ALYNCZNDIQEVRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOBENZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rvpaba lipstick"],"synonyms":["4-Aminobenzoic Acid","Aminobenzoic Acid","Aminobenzoic acid","Paba","Para-aminobenzoic acid"],"crossReferences":{"PubChem":["144204620","144208900","170466660","17388804","47193723","73461"],"Wikipedia":["4-Aminobenzoic_acid"],"drugbank":["DB02362"],"chEBI":["30753"]},"childChemblIds":["CHEMBL1564391","CHEMBL1437781","CHEMBL1762658"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL544208","canonicalSmiles":"Br.NCCc1c[nH]cn1","inchiKey":"VUDHVJRPCZJVTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTAMINE BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL90","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556371","canonicalSmiles":"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl","inchiKey":"CAOOISJXWZMLBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL556371","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL558722","canonicalSmiles":"Clc1cc(Cl)c2c(c1)CCc1ccccc1C2n1ccnc1","inchiKey":"MPTJIDOGFUQSQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBERCONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eberconazole"],"crossReferences":{"drugbank":["DB13656"],"chEBI":["83584"]},"childChemblIds":["CHEMBL4534605"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL564249","canonicalSmiles":"CS(=O)(=O)c1cccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cccc(Cl)c2)c1","inchiKey":"QRGBOABBMKYMLG-UXHICEINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL564249","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08429"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL575060","canonicalSmiles":"N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"WHUUTDBJXJRKMK-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 620","E-620","E620","FEMA NO. 3285","Glutamic acid","INS NO.620","INS-620","L-Glutamate","L-glutamic acid","NSC-143503"],"crossReferences":{"PubChem":["11113412","144206604","26751652","90340902"],"drugbank":["DB00142"],"chEBI":["16015"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL581","canonicalSmiles":"O=C(O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCc1ccccc1","inchiKey":"WOIWWYDXDVSWAZ-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSINOPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosinoprilat","SO 27,519"],"crossReferences":{"drugbank":["DB14207"],"chEBI":["116962"]},"childChemblIds":["CHEMBL361014"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL614","canonicalSmiles":"NC(=O)c1cnccn1","inchiKey":"IPEHBUMCGVEMRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZINAMIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pirilene","Pyrafat","Pyrazinamide","Tebrazid"],"synonyms":["D-50","MK-56","NSC-14911","Pyrazinamide","Pyrazinecarboxamide"],"crossReferences":{"DailyMed":["pyrazinamide"],"PubChem":["11111657","121269831","144209257","144213088","170464703","17389747","174007270","26752748","50105394","8139959","90341475"],"Wikipedia":["Pyrazinamide"],"drugbank":["DB00339"],"chEBI":["45285"]},"childChemblIds":["CHEMBL1091434"],"count":7,"approvedIndications":["EFO_1000049","Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for tuberculosis and pulmonary tuberculosis and has 5 investigational indications."}
{"id":"CHEMBL71","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"ZPEIMTDSQAKGNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORPROMAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elmarin","Largactil","Megaphen","Thorazine"],"synonyms":["Chlorpromazine","Chlorpromazine hibenzate","Chlorpromazine phenolphthalinate","Chlorpromazine tannate","J2.794D","NSC-167745","NSC-226514","SKF-2601A","Sonazine"],"crossReferences":{"DailyMed":["chlorpromazine%20hydrochloride"],"PubChem":["104171139","11110990","11110991","124879752","124879754","124879757","144203671","152146164","170465371","26747094","26747095","26751620","26751621","50100209","50104291","57287810","90340916"],"TG-GATEs":["16"],"Wikipedia":["Chlorpromazine"],"drugbank":["DB00477"],"chEBI":["3647"]},"childChemblIds":["CHEMBL1713"],"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0005407","EFO_0009267","EFO_0005799","EFO_0000692","EFO_0000519"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for psychosis and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL73234","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1","inchiKey":"CFJMRBQWBDQYMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBETAPENTANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Pentoxyverine"],"crossReferences":{"PubChem":["11113506","144204460","170465562","26751724","50104415","50104416","90340636"],"Wikipedia":["Pentoxyverine"],"drugbank":["DB11186"]},"childChemblIds":["CHEMBL1256696"],"count":1,"approvedIndications":["HP_0012735"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","HP_0012735"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cough. It was withdrawn in United States."}
{"id":"CHEMBL87","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2","inchiKey":"IAKHMKGGTNLKSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL87","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174007360","26747941","49671357"],"drugbank":["DB01394"],"chEBI":["23359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93560","canonicalSmiles":"C[C@H](O)[C@@H](CCc1cccc2ccccc12)n1cnc(C(N)=O)c1","inchiKey":"OODDZQQDDOVCFD-SCLBCKFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93560","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL96712","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"JINJZWSZQKHCIP-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEU5AC2EN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03991"],"chEBI":["28062"]},"childChemblIds":["CHEMBL3330705"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
